{"organizations": [], "uuid": "9a4d59c26c4fd8c1ffe27afb77381b6c15f462c7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-atara-biotherapeutics-posts-q4-los/brief-atara-biotherapeutics-posts-q4-loss-of-1-15-per-share-idUSASB0C7O0", "country": "US", "domain_rank": 408, "title": "BRIEF-Atara Biotherapeutics Posts Q4 Loss Of $1.15 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T14:28:00.000+02:00", "replies_count": 0, "uuid": "9a4d59c26c4fd8c1ffe27afb77381b6c15f462c7"}, "author": "", "url": "https://www.reuters.com/article/brief-atara-biotherapeutics-posts-q4-los/brief-atara-biotherapeutics-posts-q4-loss-of-1-15-per-share-idUSASB0C7O0", "ord_in_thread": 0, "title": "BRIEF-Atara Biotherapeutics Posts Q4 Loss Of $1.15 Per Share", "locations": [], "entities": {"persons": [], "locations": [{"name": "atara", "sentiment": "none"}], "organizations": [{"name": "brief-atara biotherapeutics posts", "sentiment": "negative"}, {"name": "atara biotherapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 27, 2018 / 12:29 PM / Updated 13 minutes ago BRIEF-Atara Biotherapeutics Posts Q4 Loss Of $1.15 Per Share Reuters Staff Feb 27 (Reuters) - Atara Biotherapeutics Inc: * ATARA BIOTHERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS * QTRLY LOSS PER SHARE $1.15 * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF DECEMBER 31, 2017 TOTALED $166.1 MILLION * Q4 EARNINGS PER SHARE VIEW $-1.14 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)", "external_links": [], "published": "2018-02-27T14:28:00.000+02:00", "crawled": "2018-02-27T14:47:32.057+02:00", "highlightTitle": ""}